New Strain Respiratory Virus Policy - Hampshire Hospitals NHS ...

Winchester & Eastleigh Healthcare NHS Trust
New Strain Respiratory Virus Policy
All Microbiology samples should be clearly labelled and handled as high risk.
17 PATIENT TRANSFERS
17.1 To other departments:
Risk assessment should be undertaken first. Patient transfer should be
avoided whenever possible and as many investigations as possible should be
done in the patients room. If unavoidable, the patient should wear the
recommended FFP3 mask. There are no paediatric size masks manufactured
at present. Older children can wear an FFP3 mask, younger children will not
be able to, therefore staff must also wear FFP3 masks and full PPE. Some
younger children may tolerate a water repellent mask but this does not
replace staff protection.
17.2 Ambulance transfer:
Patient should wear an FFP3 mask. Staff with the patient in the back of the
ambulance should also wear the masks and the long sleeve water repellent
gowns. The inside of the ambulance should be cleaned with chlorine releasing
agent (1000ppm) once the patient has left the ambulance, as per national
policy.
18 DECONTAMINATION OF EQUIPMENT AND ROOM
All disposable items should be disposed of as clinical waste into the bag
inside the room.
Any linen should be bagged in the alginate bag inside the room and put in the
red linen bag outside the room. Sharps box should be closed, have the
surface wiped with a disinfectant wipe and removed from the room and
processed as normal.
All other equipment, items and the floor should be should be washed/wiped
with chlorine releasing agent 1000ppm Actichlor Plus. Curtains must be
changed. Ideally the room should be decontaminated with the Bioquell
process once the patient has left the room.
Chlorine releasing agent e.g. Actichlor Plus is the recommended disinfectant
for environmental decontamination of areas where the new strain respiratory
virus patient has been in the hospital.
19 FAMILY CONTACTS:
Authorities
Document Control Information
Author: Sue Daiilly Lead Nurse Infection Type:
Policy
Control
Sponsor: Paula Shobbrook Director of Infection Scope:
Major
Prevention and Control
Reference:
CP104
Issue Number: 2
Date May 2010 Status: Final
Page 18 of 27